Literature DB >> 2785851

Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.

C Fryling1, M Dombalagian, W Burgess, N Hollander, A B Schreiber, J Haimovich.   

Abstract

The tumor inhibitory factor-2 from the conditioned medium of the human rhabdomyosarcoma cell line A673 was purified and sequenced. The 19 N-terminal amino acid residues were identical to those of human interleukin 1 (IL-1), corresponding to the residues 119-137 of the IL-1 alpha precursor. The purified material had an apparent molecular weight similar to that of the mature secreted form of IL-1 alpha (Mr 17,400). In addition, similarly to IL-1, it induced the production of IL-2 by T-cells. The purified protein inhibited the growth of the A673 cells from which it was derived, suggesting that it may act as an autocrine growth inhibitor. It also inhibited the growth of a human adenocarcinoma of the lung and three human mammary carcinomas, but not of two human melanoma cell lines. In contrast, it stimulated the proliferation of normal human fibroblasts. These biological activities, previously assigned to a putative tumor inhibitory factor molecule, are apparently due to the production by the tumor cells of IL-1 alpha.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785851

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.

Authors:  J L Klein; E Hamel; J L Tayot; H Yamasaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 Chinese hamster cells.

Authors:  I Ichinose; S Nakano; T Esaki; T Koga; K Mitsugi; H Yamada; Y Niho
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

3.  Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673.

Authors:  K Stam; A A Stewart; G Y Qu; K K Iwata; D Fenyö; B T Chait; D R Marshak; J D Haley
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

4.  The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest.

Authors:  S F Sells; S Muthukumar; V P Sukhatme; S A Crist; V M Rangnekar
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

5.  Interleukin-8 producing malignant fibrous histiocytoma with prolonged fever.

Authors:  Shunzo Osaka; Satoshi Hayakawa; Yukihiro Yoshida; Eisaku Sakurada; Junnosuke Ryu; Masahiko Sugitani
Journal:  Acta Histochem Cytochem       Date:  2006-02-15       Impact factor: 1.938

6.  A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells.

Authors:  Sophia L Maund; Lihong Shi; Scott D Cramer
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

7.  Biological response modifiers and infectious diseases: actual and potential therapeutic agents.

Authors:  J J Rusthoven
Journal:  Int J Antimicrob Agents       Date:  1994       Impact factor: 5.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.